Dwain Morris-Irvin, PhD, MPH

Research Scientist, Neurosurgery

Email:dwain.morris-irvin@cshs.org
Phone:(310) 423-7494

Academic Appointments

Assistant Professor, Neurosurgery

Awards and Activities

NIH R01 Minority Supplement Award (NINDS)2005
NIH/ NIMH & NINDS Society for Neuroscience Postdoctoral Minority Fellowship Award2003
UCLA Graduate Division Fellowship Award2001
UCLA School of Medicine, Medical Pharmacology Travel Awards2001
Ad Hoc Reviewer: Neurobiology of DiseaseCurrent
Ad Hoc Reviewer: Experimental NeurologyCurrent
Ad Hoc Reviewer: Current Stem Cell Research & TherapyCurrent
Society for Neuroscience1996
National Environmental Health Association1998 - 2002
International Society for Stem Cell Research2005

Research Focus

Neural stem cells for neurodegenerative diseases, including Parkinson's disease. Dendritic cell-based vaccination against brain tumors, including glioblastoma and tumor immunology. Examine the potential of neural stem cells for cell replacement therapy. Examine the potential of presumed tumor stem cells in tumorigenesis.

Research Contributions

Demonstrated the potential of viral gene delivery for the manipulation of neural stem and progenitor cell fates. Also, demonstrated the use of in-vivo viral gene delivery to mark and characterize neural stem and progenitor cells during development and in the pathological brain.

Current investigations include:

The role of TLR signaling in dendritic cell-based vaccination therapy against glioblastoma. Tumor immunology for the purpose of identifying novel immune targets for immunotherapy against brain tumors.

Selected Publications

  1. Ghods AJ, Irvin D, Liu G, Yuan X, Abdulkadir IR, Tunici P, Konda B, Wachsmann-Hogiu S, Black KL, Yu JS: Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells, 25(7): 1645-53, 2007
  2. Black KL, Yin D, Konda BM, Wang X, Hu J, Ko MK, Bayan JA, Sacapano MR, Espinoza AJ, Ong JM, Irvin D, Shu Y: Different effects of K(Ca) and K(ATP) agonists on brain tumor permeability between syngeneic and allogeneic rat models. Brain Res., , 2008
  3. Irvin DK, Kirik D, Björklund A, Thompson LH: In vivo gene delivery to proliferating cells in the striatum generated in response to a 6-hydroxydopamine lesion of the nigro-striatal dopamine pathway. Neurobiol. Dis., 30(3): 343-52, 2008
  4. Yin D, Wang X, Konda BM, Ong JM, Hu J, Sacapano MR, Ko MK, Espinoza AJ, Irvin DK, Shu Y, Black KL: Increase in brain tumor permeability in glioma-bearing rats with nitric oxide donors. Clin. Cancer Res., 14(12): 4002-9, 2008
  5. Wheeler CJ, Black KL, Liu G, Mazer M, Zhang XX, Pepkowitz S, Goldfinger D, Ng H, Irvin D, Yu JS: Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients. Cancer Res., 68(14): 5955-64, 2008
  6. Andersson EK, Irvin DK, Ahlsiö J, Parmar M: Ngn2 and Nurr1 act in synergy to induce midbrain dopaminergic neurons from expanded neural stem and progenitor cells. Exp. Cell Res., 313(6): 1172-80, 2006
print button
WP1